25 Nov 2021
NICE have published a full report on the recommendations for using Selpercatinib in the treatment of advanced thyroid cancer with RET alterations. The Society for Endocrinology was a key stakeholder in the consideration and production of these important recommendations.
Migraines and menopause symptoms linked to cardiovascular disease risk
19 Apr 2024
Risk of postpartum depression associated with stress during adolescence
19 Apr 2024
Surgery for hypoparathyroidism sees reduced facture rates
19 Apr 2024
Patients with type 2 diabetes taking antidepressants have a higher mortality risk
19 Apr 2024
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024